0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Systemic Atrioventricular Valve Excision and Ventricular Assist Devices in Pediatric Patients

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="S1"> <!-- named anchor --> </a> <h5 class="section-title" id="d606902e188">Background</h5> <p id="P1">Continuous-flow ventricular assist devices (CF VADs) designed for adults are increasingly used in pediatric patients. However, due to size and anatomy, there is greater risk of device inflow obstruction. </p> </div><div class="section"> <a class="named-anchor" id="S2"> <!-- named anchor --> </a> <h5 class="section-title" id="d606902e193">Methods</h5> <p id="P2">We reviewed all cases of systemic atrioventricular valve (AVV) excision with HeartWare VAD implantation in the systemic ventricle performed at our institution from November 2015 - May 2016. </p> </div><div class="section"> <a class="named-anchor" id="S3"> <!-- named anchor --> </a> <h5 class="section-title" id="d606902e198">Results</h5> <p id="P3">AVV excision with CF VAD implantation was undertaken in three patients. Patient 1 was palliated in infancy, resulting in biventricular physiology with a systemic right ventricle and presented at age 15 years with worsening ventricular dysfunction. After CF VAD implantation in the systemic ventricle and discharge to home, the patient developed tricuspid valve obstruction to VAD inflow and underwent TV excision on postoperative day 52. Patients 2 and 3 were under age 4 years with BSA 0.62 and 0.58 m <sup>2</sup> respectively, status-post Fontan palliation, with subsequent systemic ventricular dysfunction and AVV regurgitation. In both Fontan patients, the CF VAD was implanted in the right atrium with simultaneous excision of AVV. None have had evidence of elevated atrial pressures or recalcitrant pulmonary edema. At a mean follow-up of 359 days (range 304-422 days), there have been no concerns for inflow obstruction or low flow. </p> </div><div class="section"> <a class="named-anchor" id="S4"> <!-- named anchor --> </a> <h5 class="section-title" id="d606902e206">Conclusions</h5> <p id="P4">CF VAD implantation with AVV excision can successfully support complex pediatric patients in a wide range of size and anatomy (small chambers, systemic right ventricles). This technique may allow for CF VAD implantation in patients previously deemed too small for such support. </p> </div>

          Related collections

          Author and article information

          Journal
          The Annals of Thoracic Surgery
          The Annals of Thoracic Surgery
          Elsevier BV
          00034975
          January 2018
          January 2018
          : 105
          : 1
          : 170-174
          Article
          10.1016/j.athoracsur.2017.05.038
          5729091
          28821330
          0c57d680-533a-4b84-8959-3c459cbd5403
          © 2018

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article